Abstract | OBJECTIVE: METHODS: RESULTS: CONCLUSION:
|
Authors | Hidenori Mizugaki, Yutaka Fujiwara, Noboru Yamamoto, Shigehiro Yagishita, Satoru Kitazono, Ayako Tanaka, Hidehito Horinouchi, Shintaro Kanda, Hiroshi Nokihara, Koji Tsuta, Hisao Asamura, Tomohide Tamura |
Journal | Japanese journal of clinical oncology
(Jpn J Clin Oncol)
Vol. 44
Issue 9
Pg. 835-40
(Sep 2014)
ISSN: 1465-3621 [Electronic] England |
PMID | 25097183
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: [email protected]. |
Chemical References |
- Etoposide
- Irinotecan
- Carboplatin
- Cisplatin
- Camptothecin
|
Topics |
- Adenocarcinoma
(drug therapy, surgery)
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects, therapeutic use)
- Camptothecin
(administration & dosage, analogs & derivatives)
- Carboplatin
(administration & dosage)
- Carcinoma, Squamous Cell
(drug therapy, surgery)
- Chemotherapy, Adjuvant
- Cisplatin
(administration & dosage)
- Disease-Free Survival
- Drug Administration Schedule
- Etoposide
(administration & dosage)
- Female
- Humans
- Irinotecan
- Kaplan-Meier Estimate
- Lung Neoplasms
(drug therapy, pathology, surgery)
- Male
- Middle Aged
- Neoplasm Staging
- Retrospective Studies
- Small Cell Lung Carcinoma
(drug therapy, pathology, surgery)
- Treatment Outcome
|